Prevalence and Pattern of Dyslipidemia and Its Associated Factors Among Patients with Type 2 Diabetes Mellitus in Jordan: A Cross-Sectional Study

被引:17
作者
Quran, Thekraiat M. Al [1 ,5 ]
Bataineh, Ziad A. [2 ]
Al-Mistarehi, Abdel-Hameed [1 ]
Alaabdin, Anas M. Zein [1 ]
Allan, Hadeel [1 ]
Al Qura'an, Anood [3 ]
Weshah, Shatha M. [1 ]
Alanazi, Anfal A. [4 ]
Khader, Yousef S. [1 ]
机构
[1] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth & Family Med, Irbid, Jordan
[2] Jordan Univ Sci & Technol, Fac Med, Dept Gen Surg, Irbid, Jordan
[3] Jordanian Royal Med Serv, Dept Internal Med, Amman, Jordan
[4] E1 Eastern Hlth Cluster, Family Med Acad, Dammam, Saudi Arabia
[5] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth & Family Med, POB 3030, Irbid 22110, Jordan
关键词
dyslipidemia; diabetes mellitus; cholesterol; triglycerides; prevalence; CLINICAL CHARACTERISTICS; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; PRIMARY PREVENTION; GLYCEMIC CONTROL; HDL CHOLESTEROL; HEART-DISEASE; LIPID PROFILE; RISK-FACTORS; MORTALITY;
D O I
10.2147/IJGM.S377463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dyslipidemia and type 2 diabetes mellitus (T2DM) are growing health problems, particularly in developing countries. This study aimed to determine the prevalence and pattern of dyslipidemia and its associated factors among patients with T2DM. Methods: A cross-sectional study was conducted among patients with T2DM attending Family Medicine Clinics in Jordan between August 2017 and March 2019. The socio-demographics, clinical features, medications, and laboratory findings were collected. These laboratory findings included high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TGs).Results: A total of 870 patients with T2DM were included. The prevalence of dyslipidemia among patients with T2DM was 91.4%. The most common patterns of dyslipidemia were low HDL-C (66.2%), high LDL-C (62.1%), and hypertriglyceridemia (58.2%). Female gender, obesity, and hypertension were associated with diabetic dyslipidemia patterns. T2DM duration and poor glycemic control were associated with high LDL-C and hypercholesterolemia. Hypertriglyceridemia was associated with poor glycemic control and smoking.Conclusion: Dyslipidemia is highly prevalent among patients with T2DM. Evidence -based interventions are needed to prevent and control dyslipidemia among patients with T2DM in Jordan.
引用
收藏
页码:7669 / 7683
页数:15
相关论文
共 54 条
[1]  
Abdel-Aal NM, 2008, SAUDI MED J, V29, P1423
[2]   The Prevalence of Dyslipidemia among Jordanians [J].
Abujbara, Mousa ;
Batieha, Anwar ;
Khader, Yousef ;
Jaddou, Hashem ;
El-Khateeb, Mohammed ;
Ajlouni, Kamel .
JOURNAL OF LIPIDS, 2018, 2018
[3]  
Aguilar-Salinas CA, 2001, J LIPID RES, V42, P1298
[4]   Time trends in diabetes mellitus in Jordan between 1994 and 2017 [J].
Ajlouni, K. ;
Batieha, A. ;
Jaddou, H. ;
Khader, Y. ;
Abdo, N. ;
El-Khateeb, M. ;
Hyassat, D. ;
Al-Louzi, D. .
DIABETIC MEDICINE, 2019, 36 (09) :1176-1182
[5]   Pattern and determinants of dyslipidaemia in type 2 diabetes mellitus patients in Kuwait [J].
Al-Adsani, A ;
Memon, A ;
Suresh, A .
ACTA DIABETOLOGICA, 2004, 41 (03) :129-135
[6]   Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan [J].
AL-Eitan, Laith N. ;
Nassar, Ahmad M. ;
Saadeh, Nesreen A. ;
Almomani, Basima A. .
CANADIAN JOURNAL OF DIABETES, 2016, 40 (06) :496-502
[7]   Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors [J].
Al-Habori, M ;
Al-Mamari, M ;
Al-Meeri, A .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 65 (03) :275-281
[8]  
Al-Nozha MM, 2008, SAUDI MED J, V29, P282
[9]   GLYCOSYLATED HEMOGLOBIN IN DIABETES-MELLITUS - CORRELATIONS WITH FASTING PLASMA-GLUCOSE, SERUM-LIPIDS, AND GLYCOSURIA [J].
ALEYASSINE, H ;
GARDINER, RJ ;
TONKS, DB ;
KOCH, P .
DIABETES CARE, 1980, 3 (04) :508-514
[10]  
American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3